References
- Battock D.J., Grausz H., Bobrowsky M. Alternate day therapy, amphotericin B therapy in treatment of rhinocerebral phycomycosis. Annals of Internal Medicine 1968; 68: 122–136
- Bauer H., Sheldon W.H. Leukopenia with granulocytopenia in experimental mucormycosis. Journal of Experimental Medicine 1957; 106: 501–507
- Baum J.L. Rhino-orbital mucormycosis. American Journal of Opthalmology 1967; 63: 335–339
- Clark B.M. Epidemiology of phycomycosis. Systemic Mycosis, G.E. Wolstenholme, R. Porter. Churchill, London 1968; 179–205, In
- Echols R.M., Seliger D.S., Hallowell C. Rhizopus osteomyelitis. A case report and review. American Journal of Medicine 1979; 66: 141–145
- Elder T.D., Baker R.D. Pulmonary mucormycosis in rabbits with alloxan diabetes. Archives of Pathology 1956; 61: 159–168
- Eng R.H.K., Seligman S.J. Varying alternative pathway of Salmonella minnesota lipopolysaccharide-deficient mutants. Chemotherapy and Infectious Diseases, J.D. Nelson, C. Grassi. American Society for Microbiology, Washington, D.C. 1979; 832–833, In
- Fong J.S.C., Renaud L. A hemolytic plate method for alternative-pathway complement activity assay. American Journal of Clinical Pathology 1978; 69: 156–160
- Freund J.E. Mathematical Statistics. Prentice-Hall Inc., Englewood Cliff 1962; 259–261
- Gayle G.R., Welch A.M. Studies of opportunistic fungi. Inhibition of Rhizopus oryzae by human serum. American Journal of the Medical Sciences 1961; 45: 604–612
- Gluskin M., Soloman M.P., Gold B. Mucormycotic slough of nasal floor and palate in the anephric patient. Journal of the American Dental Association 1979; 98: 224–227
- Keys T.F., Haldorson A.M., Rodes K.H. Nosocomial outbreak of Rhizopus infections associated with Elastoplast wound dressings. Mortality and Morbidity Weekly Report 1978; 27: 33–34
- Kiehn T.E., Edwards F., Armstrong D., Rosen P.P., Weitsman I. Pneumonia caused by Cunninghamella bertholletiae complicating chronic lymphocytic leukemia. Journal of Clinical Microbiology 1979; 10: 374–379
- Medoff G., Kobayashi G.S. Pulmonary mucormycosis. New England Journal of Medicine 1972; 268: 86–87
- Meyer R.D., Rosen P., Armstrong D. Phycomycosis complicating leukemia and lymphoma. Annals of Internal Medicine 1972; 77: 871–879
- Myers B.R., Worser G., Hirschman S.Z. Rhinocerebral mucormycosis. Archives of Internal Medicine 1979; 139: 557–560
- Neome P., Rayner D. Mucormycosis: a report of twenty-one cases. Archives of Pathology 1960; 70: 261–268
- Record N.B., Ginder D.R. Pulmonary phycomycosis without obvious predisposing factors. Journal of the American Medical Association 1976; 235: 1256–1257
- Roth F.J., Boyd C.C., Sagami S. An evaluation of fungistatic activity of serum. Journal of Investigative Dermatology 1957; 32: 549–555
- Sheldon W.H., Bauer H. Tissue mast cells and acute inflammation in experimental cutaneous mucormycosis of normal, 48/80 treated, and diabetic rats. Journal of Experimental Medicine 1960; 112: 1069–1083
- Streets B.W., Ingle M.B. The effect of temperature on spore germination and growth of Mucor miehei in submerged culture. Canadian Journal of Microbiology 1972; 18: 975–979
- Wilson C.B., Siber G.R., O'Brien T.F. Phycomycotic gangrenous cellulitis. A report of two cases and review of literature. Archives of Surgery 1976; 11: 532–538